About Us
Registered in the USA and Nigeria; NigeriaVax is a partner of Pnuvax USA, with Vaccines and therapeutic antibody manufacturing located in Canada
Who We Are
NigeriaVax is a biotechnology company that is focused on the development of vaccines and biologics.
We plan to support all business of vaccines and biologics manufacturing production of Finished Dosage Formulations (sterile small injectable), and active biological ingredients of Biopharmaceutical Products, and critically Neglected Tropical disease (NTD) Vaccines for the west African/ Sub Sahara region.
NigeriaVax as a biopharmaceutical company will be providing clinical-stage mAb and RNA therapeutics to help in discovering and developing new innovative drugs for unfulfilled medical needs in areas such as cancers, NTD, antiviral and cardiometabolic related diseases.
Vision
Our ultimate vision at NigeriaVax is to develop and provide tailored vaccines and biopharmaceuticals to Nigerian population and Sub-Saharan regions
Mission
Manufacture high quality and affordable vaccines and biopharmaceuticals localized in Nigeria by Nigerians for the national self-sufficiency and pandemic preparedness.
Our Team
Led by Dr. Donald Gerson, Our Management Team has a cumulative over 60 years experiences in Vaccine manufacturing and Biologics production
Key Leaders
Donald F. Gerson, PhD, DSc
- PnuVax, Founder, CEO & President;
- SaudiVax, (KSA), Founder, CEO
- President and COO of Celltrion, largest CMO in Asia, 1st Asian US FDA approval for biologics
- Acambis, VP Dev & Mfg, New Process & 300 M doses Smallpox Vaccine after 9/11
- Wyeth, Managing Director for Vaccines, 50 % of US vaccine supply & Prevnar Process Development, Approval and Manufacturing
- Connaught (now Sanofi), VP Manufacturing, 80% Canadian vaccine supply, UNICEF
- Roche Basel Institute for Immunology, Scientist, worked with Niels Jerne, Georges Kohler and Susumu Tonegawa, all Nobel Prize Laureates
- Adjct. Professor of Biophysics & Chem Engineering in Canada: ~90 Publications & Patents
- PhD Biophysics, McGill, Canada. DSc. University of Western Ontario, Canada
Luke De Mayo
40 years industrial pharmaceutical, vaccine and biopharmaceutical experience
- Project Management Consultant - KMKC Consulting, Long Valley NJ.
- Project Manager - On-Board Engineering Corporation NJ / at DSM Belvedere NJ / at DSM
- Project Manager- Core Pharma Middlesex, NJ
- Project Manager - Olin Corporation Henderson, Nj
- Senior Technical Manager – Life Science GroupMiddough Parsippany, NJ
- Director - Pharmaceutical Group Paulus, Sokolowski and Sartor (PS&S) Warren, NJ
- Project Manager - Foster Wheeler, Perryville, NJ
